| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dbeab7c420445e258c1383878607491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e83bceb0cb53690622741335fe9edea |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 |
| filingDate |
2000-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21ca7ac0fe84da778ccfd8daa9a2f92d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3a38a286c842b01149a02223a9dc0c6 |
| publicationDate |
2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2362649-A |
| titleOfInvention |
Triterpenoid derivatives |
| abstract |
The present invention relates to the use of a compound of formula I, or a pharmaceutically acceptable salt thereof in therapy, particularly for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use of a compound of formula I in an assay for detecting the phosphorylation state of cellular substrates. The present invention also relates to certain novel compounds of formula I, and the chemical synthesis thereof. <EMI ID=1.1 HE=51 WI=64 LX=792 LY=1162 TI=CF> <PC>wherein the symbols are as defined in the specification. |
| priorityDate |
2000-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |